linkedin 2 twitter 2

The Biotech Council of New Jersey: 2003 Economic Impact Report

New Jersey attracts life science workers from across the nation with its access to culture, entertainment, economic and transportation centers like Philadelphia and New York City. With 124 biotechnology companies, New Jersey is now the fourth-largest biotechnology center in the nation. To assist in the development of this important industry cluster, the Biotechnology Council of New Jersey (BCNJ) was formed exclusively with representatives of biopharmaceutical, biomedical, bioagricultural and bioremedial enterprises.

Recognizing the importance of public information, the BCNJ engaged Deloitte, working together with Economic Development Research Group, to survey BCNJ members, document their economic activity in New Jersey, and identify the full range of impacts that the industry has on supporting jobs and income in the state. Results are available in the final report.

Full Report: The Biotech Council of NJ: 2003 Economic Impact Survey (pdf)

More Info on the Biotech Council of New Jersey

 

Latest Blogposts

Twitter Feed

Now available: last week's TRB webinar on ACRP's Passenger Value of Time, Benefit-Cost Analysis, & Airport Capital… https://t.co/4Y5N3iAHNM
On 9/13, Steve Landau + Glen Weisbrod will present their research from the ACRP's Passenger Value of Time, Benefit-… https://t.co/jjuXFzWcVC
On-Demand Ride Services: A Compelling Case for Research - blog by Scott Middleton https://t.co/1KrqWvIlxH https://t.co/ZFpDjQQpBD